New Evidence of TLR4 and TLR9 Variants Influencing Parasitaemia and Symptoms of Plasmodium vivax Infection
International Journal of Immunogenetics · 2025
DOI: 10.1111/iji.70014 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Immunogenetics, 2025. Verfasst von Mikaele Monik Rodrigues Inácio Silva und 8 weiteren Autor:innen. Beteiligte Einrichtung: Programa de Pós-graduação em Ciências da Saúde, Universidade Federal de Alagoas, Maceió, Alagoas, Brazil. Hauptthemen laut MEDLINE: Malaria, Vivax, Toll-Like Receptor 9, Toll-Like Receptor 4, Plasmodium vivax. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Conselho Nacional de Desenvolvimento Científico e Tecnológico, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.
Abstract (Originalsprache)
Toll‐like receptors (TLRs) induce the production of pro‐inflammatory cytokines and regulate the immune response to Plasmodium vivax infection. Genetic variants of TLRs are associated with susceptibility and severity of malaria in different populations. This study aimed to evaluate the association between polymorphisms in TLR1, TLR4, TLR7, TLR8, TLR9 and TIRAP and the clinical manifestations of malaria caused by P. vivax in a population from the Amazon region of Pará, Brazil. A total of 148 individuals with symptomatic uncomplicated malaria were genotyped for rs4833095, rs1927911, rs179008, rs3764880, rs352140 and rs8177374 variants, and their associations with parasitaemia levels, gametocytaemia and clinical index were analysed using generalised linear models. TLR9 rs352140TT homozygotes had higher parasitaemia levels than C allele carriers ( p = 0.034). TLR4 rs1927911GG homozygotes had a higher clinical index than A allele carriers ( p = 0.018). Our results describe, for the first time, the association of the rs1927911 variant found in intron 1 of TLR4 with P. vivax malaria symptoms in Brazilian Amazonian population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Programa de Pós-graduação em Ciências da Saúde, Universidade Federal de Alagoas, Maceió, Alagoas, Brazil.
- Departamento de Biologia Celular, Embriologia e Genética, Universidade Federal de Santa Catarina, Florianópolis, Santa Catarina, Brazil.
- Laboratório de Microbiologia e Imunologia, Universidade Federal do Pará, Belém, Pará, Brazil.
- Programa de Ensaios Clínicos em Malária, Instituto Evandro Chagas, Sistema de Vigilância Sanitária, Ministério da Saúde, Belém, Pará, Brazil.
- Laboratorio de Genética Humana e Médica, Programa de Pós-Graduação em Genética e Biologia Molecular, Universidade Federal do Pará, Belém, Pará, Brazil.
- Departamento de Genética, Universidade Federal do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil.
ORCID-Profile: Vinicius Albuquerque Sortica
Förderung
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
Zitieren
APA
Silva, M. M. R. I., Correia, G. M. A., Lindenau, J. D., Cunha, M. G., Ohnishi, M. D. O., Ventura, A. M. R. S., Ribeiro-Dos-Santos, Â., Hutz, M. H., & Sortica, V. A. (2025). New Evidence of TLR4 and TLR9 Variants Influencing Parasitaemia and Symptoms of Plasmodium vivax Infection. International Journal of Immunogenetics. https://doi.org/10.1111/iji.70014
Vancouver
Silva MMRI, Correia GMA, Lindenau JD, Cunha MG, Ohnishi MDO, Ventura AMRS, et al. New Evidence of TLR4 and TLR9 Variants Influencing Parasitaemia and Symptoms of Plasmodium vivax Infection. International Journal of Immunogenetics. 2025. doi:10.1111/iji.70014
BibTeX
@article{Silva2025,
author = {Silva, Mikaele Monik Rodrigues Inácio and Correia, Gabriela Maria Andrade and Lindenau, Juliana Dal-Ri and Cunha, Maristela Gomes and Ohnishi, Maria Deise Oliveira and Ventura, Ana Maria Revoredo Silva and Ribeiro-Dos-Santos, Ândrea and Hutz, Mara Helena and Sortica, Vinicius Albuquerque},
title = {New Evidence of TLR4 and TLR9 Variants Influencing Parasitaemia and Symptoms of Plasmodium vivax Infection},
journal = {International Journal of Immunogenetics},
year = {2025},
doi = {10.1111/iji.70014}
}
EUVIMED